|
Market Cap (5-Jul) $37,640,252 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (19-Jun) 470,735 (0.11%) (418th) |
|
52w High $0.130 |
52w Low $0.082 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 27 April 2022, 10:22. The announcement is not marked as price sensitive, and is 2 page(s) in length and 224.42kb in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 3.074% short sold according to ASIC data. It was ranked the 71st most shorted stock on the ASX. It remains ranked 418th as of the latest reported data (19 June 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Starpharma to present DEP at Boston ADC summit | 27 April 2022, 10:22 |
| Dr Jeff Davies appointed as director and Appendix 3X | 1 April 2022, 14:46 |
| VIRALEZE to relaunch in the UK | 1 April 2022, 10:04 |
| Application for quotation of securities - SPL | 17 March 2022, 15:15 |
You must be logged in to post a reply.
Starpharma Holdings 